Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05864118 · ClinicalTrials.gov registry record · NA
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
A NA study of Respiratory Tract Infections, sponsored by University of Nebraska.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT05864118 is a NA study of Respiratory Tract Infections that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 1,000 participants, below the 2,708-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05864118, a NA study of Respiratory Tract Infections, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Respiratory tract infections (RTIs) are prevalence community diseases and is the third leading cause of death worldwide. Rapid diagnosis of RTIs is essential as it drives decision points such as treatment, disposition, and containment. According to recent CDC (The Centers for Disease Control and Prevention) updates, nasopharyngeal swabbing is the preferred method of specimen collection for most RTIs such as SARS-COV-2. This process is invasive and traumatizing for patients as it requires probing (20 seconds) of the posterior nasopharynx with swab applicator. In some cases, this procedure has resulted in pain and injury. Because of the invasive nature of the procedure, patients often refuse testing or withdraw during the collection process resulting in inadequate specimen procurement. The study principle investigators (PI) have developed 2 novel specimen collection devices: 1) nasopharyngeal wash collection device (NP wash device) and 2) saliva collection device (the Oral Capsule). Both devices are designed for ease of use either by a healthcare professional or a patient. The benefits of such collection devices include 1) minimizing the invasive nature of the procedure because a swab applicator is not utilized and 2) minimizing infection risk to healthcare professional because the study devices can be self-administered when applicable. The study will enroll 1000 participants from a pool of patients presenting to the Nebraska Medicine Emergency Department (ED) who received a nasopharyngeal (NP) swab viral PCR test as part of their ED work up. Enrolled patients will be asked to provide four total specimens: 1) a saliva drool specimen, 2) a saliva Oral Capsule specimen, 3) a NP wash specimen, and 4) a finger stick serum specimen. Patients are able to opt out of any specimen collection method. Study specimens 1, 2, 3 will undergo a respiratory pathogen panel (RPP) PCR test and COVID-19 antibody testing. Study specimen 4 will undergo COVID-19 antibody testing and will fun
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Respiratory pathogen panel PCR test
- DIAGNOSTIC_TEST COVID-19 antibody test
Study Locations (1)
Nebraska
- Thanh Nguyen - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-08-21 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05864118
The ClinicalTrials.gov registry entry for NCT05864118 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,708-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (63% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Respiratory Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Respiratory pathogen panel PCR test is the first listed.
NCT05864118 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT05864118 about?
NCT05864118 is a clinical study titled "Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses". Respiratory tract infections (RTIs) are prevalence community diseases and is the third leading cause of death worldwide. Rapid diagnosis of RTIs is essential as it drives decision points such as treatment, disposition, and containment. According to recent CDC (The Centers for Disease Control and Pre...
What is the current status of trial NCT05864118?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2023-08-21. Estimated completion is 2026-12.
What conditions does trial NCT05864118 study?
This clinical trial studies the following conditions: Respiratory Tract Infections.
What interventions are being tested in trial NCT05864118?
The interventions under investigation include: Respiratory pathogen panel PCR test (DIAGNOSTIC_TEST), COVID-19 antibody test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05864118?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05864118 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
RECRUITING · NA
-
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
COMPLETED · NA
-
Patient Portal Flu Vaccine Reminders (RCT 6)
COMPLETED · NA
-
Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)
COMPLETED · NA
-
Hand Hygiene Randomized Cluster Intervention to Reduce Infections
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.